Bicara Therapeutics Inc (BCAX)

Investing Cash Flow

-$402.50M

TTM · Period ending: · USD

BCAX logo

BCAX Investing Cash Flow

Latest reported-$402.50M
BCAX TTM Cash from Investing (-$586.00K → -$402.50M)
High-resolution chart · PNG

BCAX investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bicara Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-402,502,000
-217,513,000
-318,453,000
-236,161,000
-48,000
-67,000
-9,000
-405,000
-547,000
-528,000
-586,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.